Cancer Research Meeting Calendar  Genetics and Biology of Brain Cancer
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Krynetski, E. Y.
Right arrow Articles by Evans, W. E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Krynetski, E. Y.
Right arrow Articles by Evans, W. E.
[Cancer Research 63, 100-106, January 2003]
© 2003 American Association for Cancer Research


Experimental Therapeutics

A Nuclear Protein Complex Containing High Mobility Group Proteins B1 and B2, Heat Shock Cognate Protein 70, ERp60, and Glyceraldehyde-3-Phosphate Dehydrogenase Is Involved in the Cytotoxic Response to DNA Modified by Incorporation of Anticancer Nucleoside Analogues1

Eugene Y. Krynetski, Natalia F. Krynetskaia, Marco E. Bianchi and William E. Evans2

Department of Pharmaceutical Sciences, St. Jude Children’s Research Hospital, Memphis, Tennessee 38105 [E. Y. K., N. F. K., W. E. E.]; University of Tennessee, Memphis, Tennessee 38163 [E. Y. K., N. F. K., W. E. E.]; and San Raffaele Scientific Insitute, via Olgettina 58, 20132 Milano, Italy [M. E. B.]

Thiopurine treatment of human leukemia cells deficient in components of the mismatch repair system (Nalm6) initiated apoptosis after incorporation into DNA, as revealed by caspase activation and terminal deoxynucleotidyl transferase-mediated nick end labeling assay. To elucidate the cellular sensor(s) responsible for recognition of DNA damage in cells with an inactive mismatch repair system, we isolated a multiprotein nuclear complex that preferentially binds DNA with thioguanine incorporated. The components of this nuclear multiprotein complex, as identified by protein mass spectroscopy, included high mobility group proteins 1 and 2 (HMGB1, HMGB2), heat shock protein HSC70, protein disulfide isomerase ERp60, and glyceraldehyde 3-phosphate dehydrogenase. The same complex was also shown to bind synthetic oligodeoxyribonucleotide duplexes containing the nonnatural nucleosides 1-ß-D-arabinofuranosylcytosine or 5-fluoro-2'-deoxyuridine. Fibroblast cell line derived from Hmgb1-/- murine embryos had decreased sensitivity to thiopurines, with an IC50 10-fold greater than Hmgb1-proficient cells (P < 0.0001) and exhibited comparable sensitivity to vincristine, a cytotoxic drug that is not incorporated into DNA. These findings indicate that the HMGB1-HMGB2-HSC70-ERp60-glyceraldehyde 3-phosphate dehydrogenase complex detects changes in DNA structure caused by incorporation of nonnatural nucleosides and is a determinant of cell sensitivity to such DNA modifying chemotherapy.




This article has been cited by other articles:


Home page
Nucleic Acids ResHome page
M. Labazi, L. Jaafar, and H. Flores-Rozas
Modulation of the DNA-binding activity of Saccharomyces cerevisiae MSH2-MSH6 complex by the high-mobility group protein NHP6A, in vitro
Nucleic Acids Res., October 20, 2009; (2009) gkp649v1.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
M. S. Phadke, N. F. Krynetskaia, A. K. Mishra, and E. Krynetskiy
Glyceraldehyde 3-Phosphate Dehydrogenase Depletion Induces Cell Cycle Arrest and Resistance to Antimetabolites in Human Carcinoma Cell Lines
J. Pharmacol. Exp. Ther., October 1, 2009; 331(1): 77 - 86.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Pathol.Home page
P. B. Romesser, D. H. Perlman, D. V. Faller, C. E. Costello, M. E. McComb, and G. V. Denis
Development of a Malignancy-Associated Proteomic Signature for Diffuse Large B-Cell Lymphoma
Am. J. Pathol., July 1, 2009; 175(1): 25 - 35.
[Abstract] [Full Text] [PDF]


Home page
Acta Biochim Biophys SinHome page
D. Mountassif, T. Baibai, L. Fourrat, A. Moutaouakkil, A. Iddar, M. S. El Kebbaj, and A. Soukri
Immunoaffinity purification and characterization of glyceraldehyde-3-phosphate dehydrogenase from human erythrocytes
Acta Biochim Biophys Sin, May 1, 2009; 41(5): 399 - 406.
[Abstract] [Full Text] [PDF]


Home page
Molecular Cancer TherapeuticsHome page
N. F. Krynetskaia, M. S. Phadke, S. H. Jadhav, and E. Y. Krynetskiy
Chromatin-associated proteins HMGB1/2 and PDIA3 trigger cellular response to chemotherapy-induced DNA damage
Mol. Cancer Ther., April 1, 2009; 8(4): 864 - 872.
[Abstract] [Full Text] [PDF]


Home page
Nucleic Acids ResHome page
S. C. Roemer, J. Adelman, M. E. A. Churchill, and D. P. Edwards
Mechanism of high-mobility group protein B enhancement of progesterone receptor sequence-specific DNA binding
Nucleic Acids Res., June 1, 2008; 36(11): 3655 - 3666.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
N. Krynetskaia, H. Xie, S. Vucetic, Z. Obradovic, and E. Krynetskiy
High Mobility Group Protein B1 Is an Activator of Apoptotic Response to Antimetabolite Drugs
Mol. Pharmacol., January 1, 2008; 73(1): 260 - 269.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
C. M. Annunziata, L. Kleinberg, B. Davidson, A. Berner, D. Gius, N. Tchabo, S. M. Steinberg, and E. C. Kohn
BAG-4/SODD and Associated Antiapoptotic Proteins Are Linked to Aggressiveness of Epithelial Ovarian Cancer
Clin. Cancer Res., November 15, 2007; 13(22): 6585 - 6592.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
C. Grillo, C. D'Ambrosio, V. Consalvi, R. Chiaraluce, A. Scaloni, M. Maceroni, M. Eufemi, and F. Altieri
DNA-binding Activity of the ERp57 C-terminal Domain Is Related to a Redox-dependent Conformational Change
J. Biol. Chem., April 6, 2007; 282(14): 10299 - 10310.
[Abstract] [Full Text] [PDF]


Home page
Cancer Epidemiol. Biomarkers Prev.Home page
J. Earl, L. Yan, L. J. Vitone, J. Risk, S. J. Kemp, C. McFaul, J. P. Neoptolemos, W. Greenhalf, for the European Registry of Hereditary Pancreatit, R. Kress, et al.
Evaluation of the 4q32-34 locus in European familial pancreatic cancer.
Cancer Epidemiol. Biomarkers Prev., October 1, 2006; 15(10): 1948 - 1955.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
S. Barker, M. Weinfeld, J. Zheng, L. Li, and D. Murray
Identification of Mammalian Proteins Cross-linked to DNA by Ionizing Radiation
J. Biol. Chem., October 7, 2005; 280(40): 33826 - 33838.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
C. Xing, J. R. LaPorte, J. K. Barbay, and A. G. Myers
Identification of GAPDH as a protein target of the saframycin antiproliferative agents
PNAS, April 20, 2004; 101(16): 5862 - 5866.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
V. M. Brown, E. Y. Krynetski, N. F. Krynetskaia, D. Grieger, S. T. Mukatira, K. G. Murti, C. A. Slaughter, H.-W. Park, and W. E. Evans
A Novel CRM1-mediated Nuclear Export Signal Governs Nuclear Accumulation of Glyceraldehyde-3-phosphate Dehydrogenase following Genotoxic Stress
J. Biol. Chem., February 13, 2004; 279(7): 5984 - 5992.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
N. F. Krynetskaia, T. L. Brenner, E. Y. Krynetski, W. Du, J. C. Panetta, P. Ching-Hon, and W. E. Evans
Msh2 Deficiency Attenuates But Does Not Abolish Thiopurine Hematopoietic Toxicity in Msh2-/- Mice
Mol. Pharmacol., August 1, 2003; 64(2): 456 - 465.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 2003 by the American Association for Cancer Research.